Skip to main content
Fig. 7 | Insights into Imaging

Fig. 7

From: MRI of diffuse-type tenosynovial giant cell tumour in the knee: a guide for diagnosis and treatment response assessment

Fig. 7

MRI findings after treatment of D-TGCT with a CSF1R inhibitor. a Axial PD SPAIR images in a patient with intra-articular D-TGCT. Baseline image showing a target lesion (two axial diameters measured according to modified RECIST, dotted lines) in the medial suprapatellar recess. Note a smaller similar lesion in the lateral suprapatellar recess. b After 8Ā weeks on CSF1R-inhibitor therapy, the tumour showed a significant decrease in size and signal intensity. Joint effusion was resolved (not shown). The patient experienced improvement in symptoms of pain and swelling. c After 36Ā weeks, residual low signal intensity hemosiderin ā€œscarsā€ remained both in the medial and lateral suprapatellar recesses

Back to article page